259 related articles for article (PubMed ID: 31885563)
1. The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy.
Tang J; Yao D; Yan H; Chen X; Wang L; Zhan H
Int J Endocrinol; 2019; 2019():8719060. PubMed ID: 31885563
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
Dewanjee S; Bhattacharjee N
Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.
Lanzaro F; Barlabà A; De Nigris A; Di Domenico F; Verde V; Miraglia Del Giudice E; Di Sessa A
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835983
[TBL] [Abstract][Full Text] [Related]
4. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
Zeng LF; Xiao Y; Sun L
Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy.
Yang S; Han Y; Liu J; Song P; Xu X; Zhao L; Hu C; Xiao L; Liu F; Zhang H; Sun L
Curr Med Chem; 2017; 24(29):3185-3202. PubMed ID: 28486920
[TBL] [Abstract][Full Text] [Related]
6. The role of microRNAs in diabetic nephropathy.
Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA Circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy.
Ge X; Xi L; Wang Q; Li H; Xia L; Cang Z; Peng W; Huang S
Gene; 2020 Oct; 758():144952. PubMed ID: 32683074
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
Zhou H; Ni WJ; Meng XM; Tang LQ
Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Management of Diabetic Nephropathy in Western Countries.
Satirapoj B; Adler SG
Kidney Dis (Basel); 2015 May; 1(1):61-70. PubMed ID: 27536666
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways in diabetic nephropathy.
Kawanami D; Matoba K; Utsunomiya K
Histol Histopathol; 2016 Oct; 31(10):1059-67. PubMed ID: 27094540
[TBL] [Abstract][Full Text] [Related]
11. The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy.
Deng J; Liu Y; Liu Y; Li W; Nie X
J Inflamm Res; 2021; 14():5273-5290. PubMed ID: 34703268
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.
Ghai V; Wu X; Bheda-Malge A; Argyropoulos CP; Bernardo JF; Orchard T; Galas D; Wang K
Kidney Int Rep; 2018 May; 3(3):555-572. PubMed ID: 29854963
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence and Management of Diabetic Nephropathy in Asia.
Tomino Y; Gohda T
Kidney Dis (Basel); 2015 May; 1(1):52-60. PubMed ID: 27536665
[TBL] [Abstract][Full Text] [Related]
14. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
16. The Role of Non-coding RNAs in Diabetic Nephropathy-Related Oxidative Stress.
He X; Kuang G; Zuo Y; Li S; Zhou S; Ou C
Front Med (Lausanne); 2021; 8():626423. PubMed ID: 33959621
[TBL] [Abstract][Full Text] [Related]
17. Role of sirtuin-1 in diabetic nephropathy.
Wang W; Sun W; Cheng Y; Xu Z; Cai L
J Mol Med (Berl); 2019 Mar; 97(3):291-309. PubMed ID: 30707256
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy, a targeted treatment for diabetic nephropathy.
Lin X; Tao L; Tang D
Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
[TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy: An update on pathogenesis and drug development.
A/L B Vasanth Rao VR; Tan SH; Candasamy M; Bhattamisra SK
Diabetes Metab Syndr; 2019; 13(1):754-762. PubMed ID: 30641802
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
Li H; Zhu X; Zhang J; Shi J
Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
